Publication | Closed Access

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia

Cholesterol MassCardiovascular DiseaseMixed HyperlipidemiaPharmacologyHyperlipidemiaPharmacotherapyLipoprotein MetabolismMedicineAtherosclerosisDyslipidemiaLipoprotein Subfractions